Lung Disease Complicates RA Care - Summary - MDSpire
From the Journals

Lung Disease Complicates RA Care

Patients with chronic lung disease had numerically lower remission rates and substantially more serious adverse events in a 5-year Japanese registry study of late-onset rheumatoid arthritis.

  • By

  • Andrea Surnit

  • May 8, 2026

  • 4 min

Share

A prospective Japanese registry study evaluated a treat-to-target strategy focusing on low disease activity for patients with late-onset rheumatoid arthritis and chronic lung disease (CLD). Involving 197 methotrexate-naïve patients aged 60 and older, the research highlighted that those with CLD faced more challenges regarding treatment adherence and adverse events. After five years, 29.8% of patients with CLD achieved remission compared to 44.0% without CLD. Results showed patients with CLD had worse health outcomes, necessitating further exploration into management strategies for this vulnerable group.

Original Source(s)

Lung Disease Complicates RA Care

  • by Andrea Surnit

  • May 8, 2026

Related Content

Serum Urate Goals Tied to Lower CV Risk

Patients with gout who reached serum urate targets had modestly higher 5-year cardiovascular event-free survival, with associations strongest among high-risk patients

Tofacitinib vs Adalimumab Findings Require Caution in RA

Meta-analysis favored tofacitinib for some rheumatoid arthritis outcomes, but high heterogeneity, dose-dependent effects, and JAK inhibitor safety concerns complicate interpretation.

Deep Remission Tied to RA Control

At 5 years, 63% of patients in the CliDR group maintained sustained remission compared with 38% in the non-CliDR group.